p53 Expression in four human medulloblastoma-derived cell lines

[1]  E. Newcomb,et al.  Loss of Heterozygosity with Mutation Frequency p 53 Mutations in Human Malignant Gliomas : Comparison of Updated , 2006 .

[2]  D. Notterman,et al.  The p53 tumor suppressor gene. , 1994, The Journal of laboratory and clinical medicine.

[3]  B. Darras,et al.  Frequency of p53 tumor suppressor gene mutations in human primary brain tumors. , 1993, Neurosurgery.

[4]  G. Reifenberger,et al.  Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. , 1993, Cancer research.

[5]  C. Purdie,et al.  Thymocyte apoptosis induced by p53-dependent and independent pathways , 1993, Nature.

[6]  Scott W. Lowe,et al.  p53 is required for radiation-induced apoptosis in mouse thymocytes , 1993, Nature.

[7]  Levine Aj.  11th Ernst Klenk Lecture. The p53 tumor suppressor gene and product. , 1993 .

[8]  C. Prives.  Doing the right thing: feedback control and p53. , 1993, Current opinion in cell biology.

[9]  J. Manfredi,et al.  The p53 tumor suppressor protein: meeting review. , 1993, Genes & development.

[10]  P. Meltzer,et al.  Amplification of a gene encoding a p53-associated protein in human sarcomas , 1992, Nature.

[11]  J. Biegel,et al.  Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors. , 1992, Cancer research.

[12]  I. Petersen,et al.  p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. , 1992, Cancer research.

[13]  L. Donehower,et al.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.

[14]  E. Newcomb,et al.  p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency. , 1992, Cancer research.

[15]  T. Mikkelsen,et al.  Clonal expansion of p53 mutant cells is associated with brain tumour progression , 1992, Nature.

[16]  G. E. Keles,et al.  Expression of glial fibrillary acidic protein in human medulloblastoma cells treated with recombinant glia maturation factor-beta. , 1992, Oncology research.

[17]  M. Berger,et al.  O6-alkylguanine DNA-alkyltransferase is not a major determinant of sensitivity to 1,3-bis(2-chloroethyl)-1-nitrosourea in four medulloblastoma cell lines. , 1992, Oncology research.

[18]  A. Levine.  The p53 tumour suppressor gene and product. , 1992, Cancer surveys.

[19]  B. Vogelstein,et al.  Participation of p53 protein in the cellular response to DNA damage. , 1991, Cancer research.

[20]  P. Kleihues,et al.  p53 mutations in nonastrocytic human brain tumors. , 1991, Cancer research.

[21]  L. Loeb,et al.  Mutator phenotype may be required for multistage carcinogenesis. , 1991, Cancer research.

[22]  A. Levine,et al.  The p53 tumour suppressor gene , 1991, Nature.

[23]  R. A. Metcalf,et al.  Mutational hot spot in the p53 gene in human hepatocellular carcinomas , 1991, Nature.

[24]  R. Metcalf,et al.  Mutational hotspot in the p53 gene in human hepatocellular carcinomas. , 1991, Nature.

[25]  W. Blattner,et al.  Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome , 1990, Nature.

[26]  P. Cogen,et al.  Deletion mapping of the medulloblastoma locus on chromosome 17p. , 1990, Genomics.

[27]  F. Collins,et al.  Mutations in the p53 gene occur in diverse human tumour types , 1989, Nature.

[28]  K. Myambo,et al.  DNA sequencing with Thermus aquaticus DNA polymerase and direct sequencing of polymerase chain reaction-amplified DNA. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Y. Nakamura,et al.  A mapped set of DNA markers for human chromosome 17. , 1988, Genomics.

[30]  W. Maltzman,et al.  UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells , 1984, Molecular and cellular biology.

[31]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[32]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.